New pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phen yl)-ureido)-3-fluro-phenoxy)-pyridine-2-c arboxylic acid for the treatment of hyper-proliferative disorders

Details for Australian Patent Application No. 2011244932 (hide)

Owner Bayer Pharmaceuticals Corporation

Inventors Dumas, Jacques; Zuleger, Susanne; Ehrlich, Paul

Agent Davies Collison Cave

Pub. Number AU-A-2011244932

Parent 2005279996

Filing date 2 November 2011

Wipo publication date 24 November 2011

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

17 November 2011 Complete Application Filed

24 November 2011 Application Open to Public Inspection

  Published as AU-A-2011244932

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011244933-Livestock handling system

2011244931-Laryngeal mask airway device